These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 24377641

  • 1. Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis.
    Kamsa-ard S, Laopaiboon M, Luvira V, Bhudhisawasdi V.
    Asian Pac J Cancer Prev; 2013; 14(11):7011-6. PubMed ID: 24377641
    [Abstract] [Full Text] [Related]

  • 2. Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study.
    Kamsa-Ard S, Luvira V, Pugkhem A, Luvira V, Thinkhamrop B, Suwanrungruang K, Bhudhisawasdi V.
    BMC Cancer; 2015 Oct 24; 15():776. PubMed ID: 26496745
    [Abstract] [Full Text] [Related]

  • 3. Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel.
    Saengsawang P, Promthet S, Bradshaw P.
    Asian Pac J Cancer Prev; 2016 Oct 24; 17(2):857-62. PubMed ID: 26925692
    [Abstract] [Full Text] [Related]

  • 4. Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
    Hanpanich P, Laha T, Sripa B, Mairiang E, Sereerak P, Upontain S, Tangkawattana P, Brindley PJ, Tangkawattana S.
    Parasitol Int; 2017 Aug 24; 66(4):464-470. PubMed ID: 27143606
    [Abstract] [Full Text] [Related]

  • 5. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
    Sudsarn P, Boonmars T, Ruangjirachuporn W, Namwat N, Loilome W, Sriraj P, Aukkanimart R, Nadchanan W, Jiraporn S.
    Pathol Oncol Res; 2016 Jan 24; 22(1):57-65. PubMed ID: 26277607
    [Abstract] [Full Text] [Related]

  • 6. Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.
    Thinkhamrop K, Khuntikeo N, Sithithaworn P, Thinkhamrop W, Wangdi K, Kelly MJ, Suwannatrai AT, Gray DJ.
    Infect Dis Poverty; 2019 Mar 20; 8(1):18. PubMed ID: 30890188
    [Abstract] [Full Text] [Related]

  • 7. Association between Repeated Praziquantel treatment and Papillary, and Intrahepatic Cholangiocarcinoma.
    Luvira V, Kamsa-Ard S, Kamsa-Ard S, Luvira V, Srisuk T, Pugkhem A, Pairojkul C, Bhudhisawasdi V.
    Ann Hepatol; 2018 Aug 24; 17(5):802-809. PubMed ID: 30145559
    [Abstract] [Full Text] [Related]

  • 8. A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model.
    Wonkchalee N, Boonmars T, Laummaunwai P, Aromdee C, Hahnvajanawong C, Wu Z, Sriraj P, Aukkanimart R, Chamgramol Y, Pairojkul C, Juasook A, Sudsarn P.
    Parasitol Res; 2013 Dec 24; 112(12):4211-9. PubMed ID: 24057695
    [Abstract] [Full Text] [Related]

  • 9. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter.
    Deenonpoe R, Chomvarin C, Pairojkul C, Chamgramol Y, Loukas A, Brindley PJ, Sripa B.
    Asian Pac J Cancer Prev; 2015 Dec 24; 16(5):1751-8. PubMed ID: 25773821
    [Abstract] [Full Text] [Related]

  • 10. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
    Buisson Y.
    Bull Soc Pathol Exot; 2017 Feb 24; 110(1):61-67. PubMed ID: 28105582
    [Abstract] [Full Text] [Related]

  • 11. Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis.
    Steele JA, Richter CH, Echaubard P, Saenna P, Stout V, Sithithaworn P, Wilcox BA.
    Infect Dis Poverty; 2018 May 17; 7(1):44. PubMed ID: 29769113
    [Abstract] [Full Text] [Related]

  • 12. A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development.
    Sriraj P, Boonmars T, Aukkanimart R, Songsri J, Sripan P, Ratanasuwan P, Boonjaraspinyo S, Wongchalee N, Laummaunwai P.
    Parasitol Res; 2016 Oct 17; 115(10):3843-52. PubMed ID: 27271702
    [Abstract] [Full Text] [Related]

  • 13. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
    Songserm N, Prasongwattana J, Sithithaworn P, Sripa B, Pipitkool V.
    Asian Pac J Cancer Prev; 2009 Oct 17; 10(2):299-302. PubMed ID: 19537899
    [Abstract] [Full Text] [Related]

  • 14. Acetaminophen Overdose Enhances Early Cholangiocarcinoma in Opisthorchiasis Hamsters.
    Sriraj P, Boonmars T, Aukkanimart R, Artchayasawat A, Borlace GN, Ratanasuwan P, Pumhirunroj B.
    Asian Pac J Cancer Prev; 2021 Dec 01; 22(12):3903-3912. PubMed ID: 34967570
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of Praziquantel Against Light Infections of Opisthorchis viverrini: A Randomized Parallel Single-Blind Dose-Ranging Trial.
    Sayasone S, Meister I, Andrews JR, Odermatt P, Vonghachack Y, Xayavong S, Senggnam K, Phongluxa K, Hattendorf J, Bogoch II, Keiser J.
    Clin Infect Dis; 2017 Feb 15; 64(4):451-458. PubMed ID: 28174906
    [Abstract] [Full Text] [Related]

  • 16. iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel.
    Pinlaor S, Hiraku Y, Yongvanit P, Tada-Oikawa S, Ma N, Pinlaor P, Sithithaworn P, Sripa B, Murata M, Oikawa S, Kawanishi S.
    Int J Cancer; 2006 Sep 01; 119(5):1067-72. PubMed ID: 16570287
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S, Wu Z, Boonmars T, Kaewkes S, Loilome W, Sithithaworn P, Nagano I, Takahashi Y, Yongvanit P, Bhudhisawasdi V.
    Parasitol Int; 2012 Mar 01; 61(1):145-50. PubMed ID: 21777692
    [Abstract] [Full Text] [Related]

  • 18. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis.
    Thanan R, Murata M, Pinlaor S, Sithithaworn P, Khuntikeo N, Tangkanakul W, Hiraku Y, Oikawa S, Yongvanit P, Kawanishi S.
    Cancer Epidemiol Biomarkers Prev; 2008 Mar 01; 17(3):518-24. PubMed ID: 18349269
    [Abstract] [Full Text] [Related]

  • 19. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P, Pinlaor S, Loilome W.
    J Hepatobiliary Pancreat Sci; 2014 May 01; 21(5):309-15. PubMed ID: 24408859
    [Abstract] [Full Text] [Related]

  • 20. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis.
    Yongvanit P, Pinlaor S, Bartsch H.
    Parasitol Int; 2012 Mar 01; 61(1):130-5. PubMed ID: 21704729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.